Supply Chain Intelligence

Bausch Health Companies Inc. Supply Chain

BHC supply chain intelligence for Bausch Health Companies Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

BHC ·Last updated 2026-10-28 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

9Suppliers
18Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Bausch Health Companies Inc. (BHC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

30Total relationships
3Distinct source URLs
9High confidence
0.754Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Bausch Health Companies Inc. Suppliers

TickerNameConfidenceEvidence
JPMORGAN-CHASE-BANK-N-A JPMORGAN-CHASE-BANK-N-A 92% the lenders and other persons party thereto, and JPMorgan Chase Bank, N.A., as administrative agent, collateral agent, swingline lender and an issuing bank
BAUSCH-LO BAUSCH-LO 75% rebates for Bausch + Lo
ALC Alcon Inc. 72% Reciprocal relationship from ALC graph: Reciprocal relationship from BHC graph: Reciprocal relationship from ALC graph: Reciprocal relationship from BHC graph: Reciprocal relationship from ALC graph:…
IRIX IRIDEX Corporation 72% Reciprocal relationship from IRIX graph: Reciprocal relationship from BHC graph: Reciprocal relationship from IRIX graph: ete by providing features and services that are valued by our customers such …
LNSR LENSAR, Inc. 72% Reciprocal relationship from LNSR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from LNSR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from LNSR gra…
NKTR Nektar Therapeutics 72% Reciprocal relationship from NKTR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from NKTR graph: the 18 µg/kg rezpegaldesleukin arm, and 11.2% for placebo (p=0.186 and p=0.12…
SLGL Sol-Gel Technologies Ltd. 72% Reciprocal relationship from SLGL graph: ay ® product candidate (one patent family has granted patents in Canada, India, Mexico, Europe and Japan (with a term until 2028) and a pending application in…
ZBIO Zenas BioPharma, Inc. 72% Reciprocal relationship from ZBIO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from ZBIO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from ZBIO gra…
BLCO Bausch + Lomb Corporation 62% Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO gra…

Bausch Health Companies Inc. Customers

TickerNameConfidenceEvidence
DURECT-CORPORATION DURECT-CORPORATION 85% e identifiable intangible assets is determined primarily using the “income approach,” which requires a forecast of the expected future cash flows (including revenue growth rates, cost of goods sold, …
PAYORS PAYORS 85% We also concentrate on managing our relationships with our payors and wholesalers
SHIBO-GROUP SHIBO-GROUP 85% ii) covered by third-party payors or (iv) profitable for distribution, is highly uncertain. The commitment periods under these agreements vary and include customary termination provisions. Expenses a…
WHOLESALERS WHOLESALERS 85% We also concentrate on managing our relationships with our payors and wholesalers
WUHAN-SHIBO-ZHENMEI-TECHNOLOGY-CO-LTD WUHAN-SHIBO-ZHENMEI-TECHNOLOGY-CO-LTD 85% ii) covered by third-party payors or (iv) profitable for distribution, is highly uncertain. The commitment periods under these agreements vary and include customary termination provisions. Expenses a…
BLCO Bausch + Lomb Corporation 72% difference between the payment due and the calculated interest at the effective interest rate of the underlying carry amount of the associated note. During the three months ended March 31, 2026 and 2…
BLCO Bausch + Lomb Corporation 72% Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC graph: difference between the payment due and the calculated interest at the effective interest rate of the underlying carry …
IRIX IRIDEX Corporation 72% Reciprocal relationship from IRIX graph: Reciprocal relationship from BHC graph: Reciprocal relationship from IRIX graph: Reciprocal relationship from BHC graph: Reciprocal relationship from IRIX gra…
KR The Kroger Co. 72% Reciprocal relationship from KR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from KR graph: Reciprocal relationship from BHC graph: Reciprocal relationship from KR graph: Re…
LNSR LENSAR, Inc. 72% Reciprocal relationship from LNSR graph: zation efforts will provide us with significant opportunity for future growth as we continue to penetrate existing and new markets. Our ALLY System currently …
MNPR Monopar Therapeutics Inc. 72% Reciprocal relationship from MNPR graph: ing on new radiopharmaceutical compounds and linkers. 11 Table of Contents Manufacturing ALXN1840 We do not currently own or operate manufacturing facilities …
RDHL RedHill Biopharma Ltd. 72% Reciprocal relationship from RDHL graph: (Prevacid ® ) and branded and generic, prescription and OTC esomeprazole magnesium (Nexium ® ). Prescription dexlansoprazole (Dexilant ®, marketed by Takeda P…
SLGL Sol-Gel Technologies Ltd. 72% Reciprocal relationship from SLGL graph: Reciprocal relationship from BHC graph: Reciprocal relationship from SLGL graph: Reciprocal relationship from BHC graph: Reciprocal relationship from SLGL gra…
VKTX Viking Therapeutics, Inc. 72% Reciprocal relationship from VKTX graph: y a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP regulations. In addition, our clinica…
XENE Xenon Pharmaceuticals Inc. 72% Reciprocal relationship from XENE graph: velopment and marketing efforts of our collaborators. • Our reliance on third parties to manufacture our product candidates may increase the risk that we will…
B-C-LTD B-C-LTD 62% difference between the payment due and the calculated interest at the effective interest rate of the underlying carry amount of the associated note. During the three months ended March 31, 2026 and 2…
OCEANSIDE-PHARMACEUTICALS-INC-BAUSCH-HEALTH-US-L OCEANSIDE-PHARMACEUTICALS-INC-BAUSCH-HEALTH-US-L 62% ejudice. Antitrust Litigation Generic Pricing Antitrust Litigation The Company and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North Ame…
VALEANT-PHARMACEUTICALS-NORTH-AMERICA-LLC VALEANT-PHARMACEUTICALS-NORTH-AMERICA-LLC 62% ejudice. Antitrust Litigation Generic Pricing Antitrust Litigation The Company and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North Ame…

Bausch Health Companies Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BHC-DEBT-8180 Xbrl Convertible 90% xbrl convertible detail from xbrl 2012-12-31.
BHC-DEBT Debt stack $20.7B 90% Market cache reports total debt of $20.7B.

Bausch Health Companies Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bausch Health Companies Inc..

Bausch Health Companies Inc. Ownership

HolderNameConfidenceEvidence
BHC-OWNER-PAULSON-CO-INC PAULSON & CO. INC. 90% 13F overlay lists PAULSON & CO. INC. as top holder; 232 tracked holders.

Bausch Health Companies Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
KR The Kroger Co. 100.00 1 ['customer']
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
EW Edwards Lifesciences Corporation 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
IRIX IRIDEX Corporation 100.00 1 ['customer', 'supplier']
BAX Baxter International Inc. 100.00 2
BLCO Bausch + Lomb Corporation 100.00 1 ['customer', 'supplier']
ACRS Aclaris Therapeutics, Inc. 100.00 2
BRX Brixmor Property Group Inc. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
COO The Cooper Companies, Inc. 100.00 2
LGND Ligand Pharmaceuticals Incorporated 100.00 2
ALC Alcon Inc. 100.00 1 ['supplier']
DNTH Dianthus Therapeutics, Inc. 100.00 2
CLYM Climb Bio, Inc. 100.00 2
COKE Coca-Cola Consolidated, Inc. 100.00 2
SLGL Sol-Gel Technologies Ltd. 100.00 1 ['customer', 'supplier']
AZN AstraZeneca PLC 100.00 2
LNSR LENSAR, Inc. 100.00 2 ['customer', 'supplier']
Browse supply chain intel →

See the full supply chain map, all relationships, and real-time alerts for Bausch Health Companies Inc..

Unlock full BHC data, View plans →
ChainSifter · Guerilla Finance support@chainsifter.com Terms Disclaimer ← Back to Map
🔐
BHC
Unlock BHC Supply Chain Data
Verified relationships include:
JPMORGAN-CHASE-BANK-N-AJPMORGAN-CHASE-BANK-N-ASupplier92%
BAUSCH-LOBAUSCH-LOSupplier75%
DURECT-CORPORATIONDURECT-CORPORATIONCustomer85%
PAYORSPAYORSCustomer85%
+26 more relationships locked
Subscribe, View plans →
Already a subscriber? Sign in →